CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 36,810	$ 25,009
Grant receivables	9,923	2,686
Prepaid expenses and other current assets	1,068	1,860
Restricted cash equivalents	190
Total current assets	47,991	29,555
Property and equipment, net	93	181
Right-of-use assets, operating leases	306	498
Total assets	48,390	30,234
Current liabilities:
Accounts payable	1,119	1,984
Accrued expenses	11,995	7,620
Deferred grant income, current	367	1,066
Operating lease liabilities, current	136	193
Other current liabilities	307	279
Total current liabilities	13,924	11,142
Operating lease liabilities, non-current	195	342
Total liabilities	14,119	11,484
Commitments and contingencies (Note 7)
Stockholders' equity:
Preferred stock, $0.001 par value, 10,000,000 shares authorized; no shares issued and outstanding at December 31, 2025 and December 31, 2024
Common stock, $0.001 par value, 250,000,000 shares authorized; 88,904,161 and 59,854,877 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively	90	60
Additional paid-in capital	232,828	193,850
Accumulated deficit	(198,647)	(175,160)
Total stockholders' equity	34,271	18,750
Total liabilities and stockholders' equity	$ 48,390	$ 30,234

The amount of current portion of deferred grant income as at the end of the reporting period.

No definition available.

Name:	cgtx_DeferredGrantIncomeCurrent
Namespace Prefix:	cgtx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).